Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jean-Louis Faudon"'
Autor:
Silvia Carlos, Carmen de Mendoza, Natalia Chueca, Vincent Soriano, Carolina Garrido, Natalia Zahonero, Katharina Skrabal, Eva Poveda, Antonio Aguilera, Federico García, Jean Louis Faudon, Vanessa Roulet
Publikováno v:
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
instname
Human immunodeficiency virus type 1 (HIV-1) tropism can be assessed using phenotypic assays, but this is quite laborious, expensive, and time-consuming and can be made only in sophisticated laboratories. More accessible albeit reliable tools for test
Autor:
María del Mar González, Katharina Skrabal, Jean-Louis Faudon, Vincent Soriano, Verónica Briz, Vanessa Roulet, Eva Poveda
Publikováno v:
AIDS. 21:1487-1490
The predictive value of three genotypic methods to determine HIV-1 co-receptor usage was assessed in 83 plasma specimens taking as reference the results obtained using a recombinant phenotypic assay (Phenoscript). The best concordance was found for w
Autor:
Laurent Thibaut, Claire-Marie Thomas, Laurent Essioux, Jean-Louis Faudon, Séverine Rochas, Elisabeth Dam, Sophie Lebel-Binay, Andrew F. Hill, François Clavel, Malte Schutz
Publikováno v:
Antiviral Therapy. 12:371-380
BackgroundDouble-boosted protease inhibitors (PIs) are under investigation for the treatment of patients who are unable to take nucleoside reverse transcriptase inhibitors because of cross-resistance and/or intolerance. Evidence of synergistic inhibi
Autor:
François Clavel, José Miguel Benito, Jean-Louis Labernardière, Jonathan M. Schapiro, Carlos Toro, Berta Rodés, Vincent Soriano, Jean-Louis Faudon, Eva Poveda, Juan González-Lahoz
Publikováno v:
Journal of Medical Virology. 74:21-28
Four heavily antiretroviral-experienced HIV-infected patients had significant plasma HIV-RNA reductions (>1 log) after beginning an Enfuvirtide (ENF)-based rescue regimen. However, all had viral rebound shortly thereafter, sustaining high levels of p
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 38(2)
Background Data on susceptibility of HIV-1 non-B subtypes to Enfuvirtide (ENF) is rather limited. Objective To determine if ENF could be active in vitro against HIV-1 non-B subtypes and how the gp41 genetic variability across variants may influence E
Autor:
Sophie Lebel-Binay, Vincent Soriano, Jean-Louis Faudon, Eva Poveda, Victoria Jiménez, Berta Rodés
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 34(4)
Enfuvirtide (ENF) is the first of a novel class of drugs that blocks HIV fusion to host cells. We analyzed the dynamics of genotypic and phenotypic resistance to ENF during and after long-term ENF therapy and its clinical implications in eight heavil
Autor:
Eva, Poveda, Berta, Rodés, Jean-Louis, Labernardière, José Miguel, Benito, Carlos, Toro, Juan, González-Lahoz, Jean-Louis, Faudon, François, Clavel, Jonathan, Schapiro, Vincent, Soriano
Publikováno v:
Journal of medical virology. 74(1)
Four heavily antiretroviral-experienced HIV-infected patients had significant plasma HIV-RNA reductions (1 log) after beginning an Enfuvirtide (ENF)-based rescue regimen. However, all had viral rebound shortly thereafter, sustaining high levels of pl
Autor:
Sandra Durantel, L. Barraud, K. Skrabal, Sophie Lebel-Binay, Jean-Louis Faudon, A. Ollivet, David Durantel, G. Avenard, Fabien Zoulim
Publikováno v:
Journal of Clinical Virology. 36:S89-S90
Autor:
K. Skrabal, S. Lebel Binay, Christian Pichoud, Sandra Durantel, Stéphanie Villet, Jean-Louis Faudon, Luc Barraud, Fabien Zoulim
Publikováno v:
Journal of Hepatology. 48:S253
Autor:
Milos Opravil, Lee T. Bacheler, Jonathan M. Schapiro, A Horban, William W. Hall, A. De Luca, N. Dedes, E. Shulse, M Youle, Giorgio Gatti, T. W. Myers, Tomás Pumarola, Angelos Hatzakis, Ricardo Jorge Camacho, Carlo Federico Perno, Jean-Claude Schmit, Rainer Ziermann, Michael D. Miller, Nathan Clumeck, Schlomo Staszewski, Vincent Soriano, Mika Salminen, Jan Albert, Luc Perrin, Jean-Louis Faudon, Jan Gerstoft, Nicholas S. Hellmann, Lidia Ruiz, Deenan Pillay, P. Clevenbergh, Veronica Miller, Anne-Mieke Vandamme, Françoise Brun-Vézinet, Stefano Vella, Barbara Schmidt, Jens D Lundgren, Hans Wilhelm Doerr, Lucia Palmisano, Rob Schuurman, Dénes Bánhegyi, Dale J. Kempf, Anders Sönnerborg, Andrew N. Phillips, Claus Nielsen, Birgitta Åsjö, Mounir Ait-Khaled, Charles A. Boucher
Publikováno v:
Europe PubMed Central
Scopus-Elsevier
ResearcherID
Web of Science
Università degli Studi di Siena-IRIS
Scopus-Elsevier
ResearcherID
Web of Science
Università degli Studi di Siena-IRIS
In most European countries, HIV drug resistance testing has become a routine clinical tool. However, its practical implementation in a clinical context is demanding. The European HIV Drug Resistance Panel was established to make recommendations to cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bc7674da7f2d1435c9a1c82776d2440
http://europepmc.org/abstract/med/15651743
http://europepmc.org/abstract/med/15651743